Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery resulted in stroke survivors being more likely to have better function 90 days ...

Eylea (aflibercept) injections can cause both mild and serious side effects, though serious side effects are rare according to clinical trials. Mild side effects include eye floaters, redness, and ...

Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery resulted in stroke survivors being more likely to have better function 90 days ...

Patients hospitalized with fractures typically receive an injectable blood thinner, low-molecular-weight heparin, to prevent life-threatening blood clots. A new clinical trial, however, found that ...

Every year, millions of people develop dangerous blood clots in their legs without realizing the life-threatening risk growing within their bodies. These formations, medically known as deep vein ...

Every year, nearly 900,000 Americans are affected by venous thromboembolism (VTE), a condition in which blood clots form in the veins and can migrate to the lungs. These types of blood clots need ...

Blood clots, while often silent, can become life-threatening if not identified and treated promptly. These dangerous blockages in the bloodstream pose a significant risk to health, making awareness of ...

Sitting still for long periods during travel may increase the risk of developing blood clots. Untreated blood clots may lead to serious and even life threatening complications, like pulmonary embolism ...

For more than a century, heart disease has remained one of the leading causes of death in the United States and many other countries. Heart attacks and strokes kill millions of people every year, ...

An aortic thrombosis is a blood clot that forms in the aorta, the primary artery leading away from the heart. It is rare but is a medical emergency. An aortic thrombosis can disrupt the seamless flow ...

Patients hospitalized with fractures typically receive an injectable blood thinner, low-molecular-weight heparin, to prevent life-threatening blood clots. A new clinical trial, however, found that ...